OncLive - Bringing the Oncology Community Together

Paul A. Hamlin, MD, discusses exciting updates from the 2017 ASH Annual Meeting throughout the large cell lymphoma space, as well as other advances on the horizon. Read More >>

Expert Highlights Incorporation of Neoadjuvant Endocrine Therapy Into ER+ Breast Cancer

Following FDA Approvals, CML Pipeline Has Challenges

Hurvitz Shares Insight on Breaking the Barrier With Biosimilars

FDA Approval Sought for Gilteritinib in FLT3+ AML

Immunotherapy's Role in TNBC May Be in Combination

View More Stories >>

View Conference Coverage

2018 AACR Annual Meeting

2018 European Lung Cancer Congress

2018 SGO Annual Meeting

2018 State of the Science Summit on Gastrointestinal Malignancies

2018 State of the Science Summit on Prostate Cancer

Dr. Bergsagel on Competing Philosophies of Treatment in Patients With Relapsed Myeloma

Dr. Htut on CAR T-Cell Therapy in Patients With Multiple Myeloma

Dr. Callahan on Endocrine Therapy in Patients With ER-Positive Breast Cancer

Dr. Roussos Torres on the Potential for Immunotherapy in HER2+ Breast Cancer

Dr. Wei on Immune-Related Adverse Events in GU Cancers

Dr. Simeone Discusses Unmet Needs in Pancreatic Cancer

Dr. Slamon Discusses the Approval Process for Biosimilars

OncLive houses thousands of videos that provide updates and information.
See more Videos

$Third-Line Treatment in Refractory CRC$

Third-Line Treatment in Refractory CRC

$Immunotherapy Options in Refractory CRC$

Immunotherapy Options in Refractory CRC

Guidelines for Early Detection of Metastasis in CRPC

Metastatic Renal Cell Carcinoma: When to Switch Therapy

Treatment Challenges in Nonmetastatic CRPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Immunotherapy with Antiangiogenics in NSCLC

Diagnostic Evaluation of HCC

Immunotherapy in Metastatic NSCLC

Patient Selection for Frontline Bevacizumab in NSCLC

Rationale Behind Antiangiogenic Therapy in NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

FDA Approves Blinatumomab for MRD+ ALL

The FDA has granted an accelerated approval to blinatumomab for the treatment of adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia who are in remission but still have minimal residual disease.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in RCC and Chronic ITP, 2018 ELCC Highlights, and More